Five key drug discovery deals of summer 2023
Drug Discovery World
AUGUST 9, 2023
The news followed an announcement that Biogen would be cutting around 1,000 jobs, or 11% of its workforce, to allow investment into its product pipeline. We are very excited to continue the development of sepofarsen and ultevursen for patients,” said Jean-Frédéric Chibret, President of the Théa group.
Let's personalize your content